[
  {
    "drug_name": "alvespimycin",
    "brd_id": "BRD-K83988098-003-01-8",
    "sig_id": "CPC014_PC3_6H:BRD-K83988098-003-01-8:10",
    "score": -11.5519,
    "pvalue": 1.88832904763962e-07,
    "qvalue": 0.00114569675489634,
    "zscore": 1.718030001330714,
    "cell_line": "PC3",
    "dose": "10",
    "time": "6H",
    "moa": "HSP inhibitor",
    "target": "HSP90AA1",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "tretinoin",
    "brd_id": "BRD-K71879491-001-17-6",
    "sig_id": "ASG001_MCF7_6H:BRD-K71879491-001-17-6:10",
    "score": -10.9953,
    "pvalue": 1.35681487934146e-06,
    "qvalue": 0.00149273478441859,
    "zscore": 1.8739407271816122,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "retinoid receptor agonist | retinoid receptor ligand",
    "target": "ALDH1A1 | ALDH1A2 | GPRC5A | NR0B1 | NR2C2 | PPARD | RARA | RARB | RARG | RARRES1 | RORB | RORC | RXRB | RXRG",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-K35716340-001-02-0",
    "brd_id": "BRD-K35716340-001-02-0",
    "sig_id": "CPC006_HEC108_6H:BRD-K35716340-001-02-0:12",
    "score": -10.7093,
    "pvalue": 1.24420038523675e-06,
    "qvalue": 0.00149273478441859,
    "zscore": 1.813567367784469,
    "cell_line": "HEC108",
    "dose": "12",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-A79465854-001-01-3",
    "brd_id": "BRD-A79465854-001-01-3",
    "sig_id": "CPC006_HT29_6H:BRD-A79465854-001-01-3:10",
    "score": -10.4845,
    "pvalue": 1.83723458510701e-06,
    "qvalue": 0.00149273478441859,
    "zscore": 1.8279028222126903,
    "cell_line": "HT29",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BIBR-1532",
    "brd_id": "BRD-K04623885-001-03-4",
    "sig_id": "CPC006_A673_6H:BRD-K04623885-001-03-4:80",
    "score": -10.3899,
    "pvalue": 1.92994895716056e-06,
    "qvalue": 0.00149273478441859,
    "zscore": 1.818181969739441,
    "cell_line": "A673",
    "dose": "80",
    "time": "6H",
    "moa": "telomerase inhibitor",
    "target": "TERT",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "Amg-9810",
    "brd_id": "BRD-K43068349-001-01-9",
    "sig_id": "CPC004_VCAP_24H:BRD-K43068349-001-01-9:10",
    "score": -10.3604,
    "pvalue": 1.89861096462454e-06,
    "qvalue": 0.00149273478441859,
    "zscore": 1.810761310072836,
    "cell_line": "VCAP",
    "dose": "10",
    "time": "24H",
    "moa": "TRPV antagonist",
    "target": "TRPV1",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "motesanib",
    "brd_id": "BRD-K99616396-316-01-2",
    "sig_id": "CPC013_MCF7_24H:BRD-K99616396-316-01-2:10",
    "score": -10.1806,
    "pvalue": 1.28824861194437e-06,
    "qvalue": 0.00149273478441859,
    "zscore": 1.728451758543597,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "24H",
    "moa": "KIT inhibitor | PDGFR tyrosine kinase receptor inhibitor | VEGFR inhibitor",
    "target": "FLT1 | FLT4 | KDR | KIT | PDGFRA | RET",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one",
    "brd_id": "BRD-K51816706-001-01-7",
    "sig_id": "CPC001_VCAP_24H:BRD-K51816706-001-01-7:10",
    "score": -10.0969,
    "pvalue": 7.60662322813576e-06,
    "qvalue": 0.00332922730570087,
    "zscore": 1.9725191932724817,
    "cell_line": "VCAP",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BIIB021",
    "brd_id": "BRD-K51967704-001-01-0",
    "sig_id": "CPC013_HA1E_6H:BRD-K51967704-001-01-0:10",
    "score": -9.9935,
    "pvalue": 2.05975056978338e-06,
    "qvalue": 0.00149273478441859,
    "zscore": 1.7575043242335338,
    "cell_line": "HA1E",
    "dose": "10",
    "time": "6H",
    "moa": "HSP inhibitor",
    "target": "AOX1 | HSP90AA1",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "N'-benzoyl-2-phenyl-4-thiazolecarbohydrazide",
    "brd_id": "BRD-K20032655-001-01-0",
    "sig_id": "CPC013_HA1E_6H:BRD-K20032655-001-01-0:10",
    "score": -9.9254,
    "pvalue": 1.96172682799424e-06,
    "qvalue": 0.00149273478441859,
    "zscore": 1.7390458690680584,
    "cell_line": "HA1E",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "MK-1775",
    "brd_id": "BRD-K54256913-001-01-2",
    "sig_id": "CPC006_MCF7_24H:BRD-K54256913-001-01-2:10",
    "score": -9.9001,
    "pvalue": 2.57433584687985e-06,
    "qvalue": 0.00155217948266309,
    "zscore": 1.7712473719566983,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "24H",
    "moa": "WEE1 kinase inhibitor",
    "target": "WEE1",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "KU-55933",
    "brd_id": "BRD-K25311561-001-03-2",
    "sig_id": "CPC014_PC3_6H:BRD-K25311561-001-03-2:10",
    "score": -9.8181,
    "pvalue": 1.63555003002061e-06,
    "qvalue": 0.00149273478441859,
    "zscore": 1.6967786617949168,
    "cell_line": "PC3",
    "dose": "10",
    "time": "6H",
    "moa": "ATM kinase inhibitor",
    "target": "ATM | PRKDC",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "N-(2-aminophenyl)-4-[[[(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzamide",
    "brd_id": "BRD-K37043259-001-01-8",
    "sig_id": "CPC019_VCAP_24H:BRD-K37043259-001-01-8:10",
    "score": -9.8176,
    "pvalue": 1.4530650240598e-06,
    "qvalue": 0.00149273478441859,
    "zscore": 1.6817531425457515,
    "cell_line": "VCAP",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-K35483542-001-04-9",
    "brd_id": "BRD-K35483542-001-04-9",
    "sig_id": "CPC014_MCF7_6H:BRD-K35483542-001-04-9:10",
    "score": -9.8034,
    "pvalue": 1.83723458510701e-06,
    "qvalue": 0.00149273478441859,
    "zscore": 1.7091428032680973,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-A59193861-001-02-4",
    "brd_id": "BRD-A59193861-001-02-4",
    "sig_id": "CPC013_MCF7_24H:BRD-A59193861-001-02-4:10",
    "score": -9.7024,
    "pvalue": 2.26837260760638e-06,
    "qvalue": 0.00149395019936956,
    "zscore": 1.718977797307845,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRL-37344",
    "brd_id": "BRD-K07507905-236-01-8",
    "sig_id": "CPC003_PC3_6H:BRD-K07507905-236-01-8:10",
    "score": -9.6383,
    "pvalue": 7.99846738278382e-06,
    "qvalue": 0.00332922730570087,
    "zscore": 1.890975484710034,
    "cell_line": "PC3",
    "dose": "10",
    "time": "6H",
    "moa": "adrenergic receptor agonist",
    "target": "ADRB1 | ADRB2 | ADRB3",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "Cefdinir, (E)-",
    "brd_id": "BRD-K52735702-001-01-2",
    "sig_id": "CPC010_HT29_6H:BRD-K52735702-001-01-2:10",
    "score": -9.2074,
    "pvalue": 8.68880714070075e-06,
    "qvalue": 0.00332922730570087,
    "zscore": 1.819270410540443,
    "cell_line": "HT29",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "Retinoic Acid",
    "brd_id": "BRD-K06926592-001-01-7",
    "sig_id": "CPC016_MCF7_6H:BRD-K06926592-001-01-7:10",
    "score": -9.1755,
    "pvalue": 3.34280652994914e-06,
    "qvalue": 0.00170359767548325,
    "zscore": 1.675627246865084,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "1-Naphthalenesulfonic acid, 3-hydroxy-4-[2-(1-hydroxy-2-naphthalenyl)diazenyl]-7-nitro-",
    "brd_id": "BRD-K16233984-236-01-4",
    "sig_id": "CPC002_PC3_24H:BRD-K16233984-236-01-4:10",
    "score": -9.0551,
    "pvalue": 1.41673229857425e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.8675240366163097,
    "cell_line": "PC3",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-A16820783-001-06-0",
    "brd_id": "BRD-A16820783-001-06-0",
    "sig_id": "CPC009_MCF7_24H:BRD-A16820783-001-06-0:10",
    "score": -9.0097,
    "pvalue": 1.10637017862647e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.8179068799050793,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-A55594068-065-02-3",
    "brd_id": "BRD-A55594068-065-02-3",
    "sig_id": "MUC.CP006_MCF7_24H:BRD-A55594068-065-02-3:10",
    "score": -8.9931,
    "pvalue": 2.82625328566773e-06,
    "qvalue": 0.00157128671306688,
    "zscore": 1.6207385568841453,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "terfenadine",
    "brd_id": "BRD-A06352418-001-15-0",
    "sig_id": "CPC015_MCF7_6H:BRD-A06352418-001-15-0:10",
    "score": -8.8987,
    "pvalue": 8.83265062154305e-06,
    "qvalue": 0.00332922730570087,
    "zscore": 1.7607621472069144,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "histamine receptor antagonist",
    "target": "HRH1 | KCNH1 | KCNH2",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-A32595718-001-04-3",
    "brd_id": "BRD-A32595718-001-04-3",
    "sig_id": "CPC008_PC3_6H:BRD-A32595718-001-04-3:10",
    "score": -8.7282,
    "pvalue": 1.41673229857425e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.8001101394711618,
    "cell_line": "PC3",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "loperamide",
    "brd_id": "BRD-K61250553-003-13-2",
    "sig_id": "CPC006_HT29_24H:BRD-K61250553-003-13-2:10",
    "score": -8.6337,
    "pvalue": 1.71917047600424e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.8120151472385913,
    "cell_line": "HT29",
    "dose": "10",
    "time": "24H",
    "moa": "opioid receptor agonist",
    "target": "CACNA1A | CALM1 | CYP2B6 | CYP2C8 | NPR2 | OPRD1 | OPRK1 | OPRM1 | POMC",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-K03670461-001-02-0",
    "brd_id": "BRD-K03670461-001-02-0",
    "sig_id": "CPC004_MCF7_6H:BRD-K03670461-001-02-0:10",
    "score": -8.594,
    "pvalue": 1.93052658300249e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.8229596020361314,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-K49094915-019-01-5",
    "brd_id": "BRD-K49094915-019-01-5",
    "sig_id": "CPC009_HA1E_6H:BRD-K49094915-019-01-5:10",
    "score": -8.5278,
    "pvalue": 1.69415485313623e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.7873991385591308,
    "cell_line": "HA1E",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "N'-[(E)-(2-hydroxynaphthalen-1-yl)methylideneamino]-N-(2-hydroxyphenyl)octanediamide",
    "brd_id": "BRD-K35004659-001-01-8",
    "sig_id": "CPC012_MCF7_6H:BRD-K35004659-001-01-8:10",
    "score": -8.3654,
    "pvalue": 1.74449120968632e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.75805570157377,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-K28916077-001-04-0",
    "brd_id": "BRD-K28916077-001-04-0",
    "sig_id": "CPC010_A549_6H:BRD-K28916077-001-04-0:10",
    "score": -8.3072,
    "pvalue": 1.93052658300249e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.7621147012608471,
    "cell_line": "A549",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "(1R,5R,6R,7S)-6-methyl-1,3,7-tris(3-methylbut-2-enyl)-5-(2-methyl-1-oxopropyl)-6-(4-methylpent-3-enyl)bicyclo[3.3.1]nonane-2,4,9-trione",
    "brd_id": "BRD-A80775386-001-01-9",
    "sig_id": "CPC014_MCF7_6H:BRD-A80775386-001-01-9:10",
    "score": -8.2775,
    "pvalue": 1.66944144806136e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.7326186521985616,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "taurocholate",
    "brd_id": "BRD-K81062487-001-03-3",
    "sig_id": "NMH002_NPC_24H:BRD-K81062487-001-03-3:10",
    "score": -8.2703,
    "pvalue": 1.07189916043866e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.6640917941189155,
    "cell_line": "NPC",
    "dose": "10",
    "time": "24H",
    "moa": "G protein-coupled receptor agonist",
    "target": "CEL | FABP6 | SLCO1C1",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-K66792149-001-01-8",
    "brd_id": "BRD-K66792149-001-01-8",
    "sig_id": "CPC006_SW948_6H:BRD-K66792149-001-01-8:11.1",
    "score": -8.2223,
    "pvalue": 2.41802919729547e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.7810556472662171,
    "cell_line": "SW948",
    "dose": "11.1",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "benperidol",
    "brd_id": "BRD-K79425933-001-03-6",
    "sig_id": "CPC016_A375_6H:BRD-K79425933-001-03-6:10",
    "score": -8.1186,
    "pvalue": 1.71917047600424e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.7039220695813477,
    "cell_line": "A375",
    "dose": "10",
    "time": "6H",
    "moa": "dopamine receptor antagonist",
    "target": "DRD2",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-K95138506-019-01-8",
    "brd_id": "BRD-K95138506-019-01-8",
    "sig_id": "CPC009_A549_24H:BRD-K95138506-019-01-8:10",
    "score": -8.1066,
    "pvalue": 2.28754864411595e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.7468782097165658,
    "cell_line": "A549",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "SB-225002",
    "brd_id": "BRD-K61323504-001-03-2",
    "sig_id": "CPC006_A375_24H:BRD-K61323504-001-03-2:11.1",
    "score": -8.0949,
    "pvalue": 2.69747824849699e-05,
    "qvalue": 0.00337316427465495,
    "zscore": 1.7716809487514498,
    "cell_line": "A375",
    "dose": "11.1",
    "time": "24H",
    "moa": "CC chemokine receptor antagonist",
    "target": "CXCR2",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "Retinol",
    "brd_id": "BRD-K64634304-001-01-5",
    "sig_id": "MUC.CP001_MCF7_24H:BRD-K64634304-001-01-5:1.4815",
    "score": -8.094,
    "pvalue": 1.31284249654519e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.6579996693506285,
    "cell_line": "MCF7",
    "dose": "1.4815",
    "time": "24H",
    "moa": "retinoid receptor ligand",
    "target": "ALDH1A1 | ALDH1A2 | ALDH1A3 | DHRS3 | DHRS4 | LRAT | NR2C2 | RBP1 | RBP3 | RDH11 | RDH12 | RDH13 | RDH14 | RDH5 | RDH8 | RETSAT | RHO | RLBP1 | RXRA | RXRB | RXRG",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-K28296557-005-14-6",
    "brd_id": "BRD-K28296557-005-14-6",
    "sig_id": "CPC006_MCF7_24H:BRD-K28296557-005-14-6:10",
    "score": -8.0732,
    "pvalue": 2.66115476612682e-05,
    "qvalue": 0.00335062865832715,
    "zscore": 1.7646610375051501,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "menadione",
    "brd_id": "BRD-K78126613-001-16-0",
    "sig_id": "CPC018_MCF7_6H:BRD-K78126613-001-16-0:10",
    "score": -7.9685,
    "pvalue": 1.74449120968632e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.674645742940889,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "mitochondrial DNA polymerase inhibitor | phosphatase inhibitor",
    "target": "AOX1 | BGLAP | F10 | F2 | F7 | F9 | GGCX | NQO1 | NQO2 | PKM | PROC | PROS1 | PROZ | VKORC1 | VKORC1L1",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-A54632525-001-03-2",
    "brd_id": "BRD-A54632525-001-03-2",
    "sig_id": "CPC010_PC3_24H:BRD-A54632525-001-03-2:10",
    "score": -7.8362,
    "pvalue": 2.77135390491556e-05,
    "qvalue": 0.00338002533662479,
    "zscore": 1.7194781892130813,
    "cell_line": "PC3",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "parthenolide",
    "brd_id": "BRD-K98548675-001-02-6",
    "sig_id": "CPC018_NPC_24H:BRD-K98548675-001-02-6:10",
    "score": -7.8308,
    "pvalue": 2.35204126897098e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.69184135848093,
    "cell_line": "NPC",
    "dose": "10",
    "time": "24H",
    "moa": "NFkB pathway inhibitor",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-K70977695-001-04-1",
    "brd_id": "BRD-K70977695-001-04-1",
    "sig_id": "CPC010_PC3_24H:BRD-K70977695-001-04-1:10",
    "score": -7.8058,
    "pvalue": 3.08377037527131e-05,
    "qvalue": 0.00357759149037911,
    "zscore": 1.7304301267826308,
    "cell_line": "PC3",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "1,3-Benzothiazol-2-yl(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile",
    "brd_id": "BRD-A60245366-001-01-1",
    "sig_id": "CPC014_ASC_24H:BRD-A60245366-001-01-1:10",
    "score": -7.7772,
    "pvalue": 2.48553938992566e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.689006941930701,
    "cell_line": "ASC",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "GW-7647",
    "brd_id": "BRD-K96263742-001-02-3",
    "sig_id": "CPC015_ASC_24H:BRD-K96263742-001-02-3:10",
    "score": -7.7055,
    "pvalue": 2.58971873390733e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.6799549225255155,
    "cell_line": "ASC",
    "dose": "10",
    "time": "24H",
    "moa": "PPAR receptor agonist",
    "target": "PPARA",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "trichostatin-a",
    "brd_id": "BRD-K68202742-001-06-6",
    "sig_id": "CPC012_SKB_24H:BRD-K68202742-001-06-6:10",
    "score": -7.6011,
    "pvalue": 3.51459012871661e-05,
    "qvalue": 0.00386776577944035,
    "zscore": 1.7065410084724129,
    "cell_line": "SKB",
    "dose": "10",
    "time": "24H",
    "moa": "HDAC inhibitor",
    "target": "HDAC1 | HDAC10 | HDAC2 | HDAC3 | HDAC4 | HDAC5 | HDAC6 | HDAC7 | HDAC8 | HDAC9",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "LY2183240",
    "brd_id": "BRD-K37865504-001-02-5",
    "sig_id": "CPC006_HCC515_24H:BRD-K37865504-001-02-5:10",
    "score": -7.595,
    "pvalue": 3.84473485359412e-05,
    "qvalue": 0.00418802173912241,
    "zscore": 1.7202251997464788,
    "cell_line": "HCC515",
    "dose": "10",
    "time": "24H",
    "moa": "FAAH inhibitor | FAAH reuptake inhibitor",
    "target": "FAAH",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "IKK-2-inhibitor-V",
    "brd_id": "BRD-K74305673-001-02-1",
    "sig_id": "CPC018_MCF7_6H:BRD-K74305673-001-02-1:10",
    "score": -7.5799,
    "pvalue": 2.58971873390733e-05,
    "qvalue": 0.00332922730570087,
    "zscore": 1.6525569750719904,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "IKK inhibitor | NFkB pathway inhibitor",
    "target": "IKBKB",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "Dimethyl 12-ethyl-4-(17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl)-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10,11-dicarboxylate",
    "brd_id": "BRD-A76528577-065-01-2",
    "sig_id": "CPC016_A375_6H:BRD-A76528577-065-01-2:10",
    "score": -7.5447,
    "pvalue": 2.8468917473792e-05,
    "qvalue": 0.00342338732622349,
    "zscore": 1.6597701806261957,
    "cell_line": "A375",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "scriptaid",
    "brd_id": "BRD-K22503835-001-06-0",
    "sig_id": "CPC015_SKB_24H:BRD-K22503835-001-06-0:10",
    "score": -7.3939,
    "pvalue": 3.29337612591495e-05,
    "qvalue": 0.0037101222256964,
    "zscore": 1.6495592538145136,
    "cell_line": "SKB",
    "dose": "10",
    "time": "24H",
    "moa": "HDAC inhibitor",
    "target": "HDAC1 | HDAC2 | HDAC3 | HDAC4 | HDAC5 | HDAC6 | HDAC7 | HDAC8 | HDAC9",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "N-(2-aminophenyl)-4-[[[(2S,3R)-10-[[anilino(oxo)methyl]amino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzamide",
    "brd_id": "BRD-K55116708-001-01-6",
    "sig_id": "CPC019_A549_24H:BRD-K55116708-001-01-6:10",
    "score": -7.1162,
    "pvalue": 4.4699582199189e-05,
    "qvalue": 0.0047838610359127,
    "zscore": 1.6360132233621212,
    "cell_line": "A549",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  }
]